University of Pennsylvania is working on a treatment for solid tumours and its only known investor is HLB Pharmaceutical.

Limited partners include drugs maker Pfizer, and healthcare-focused JSR Group and Lonza.

Vehicle charging technology developer Virta has closed an Eneos-backed round at $36m while Hubert Burda-backed wealth manager StashAway pushed its total funding past $60m.

3M-backed CNS disorder therapy developer Impel priced its initial public offering in the middle of its range, giving it a $290m market cap.

SenseTime and Sinopharm Capital have contributed to the oncology surgical device developer’s latest round, which will fund sales, marketing, product and technology improvement.

Deerfield Management has added Empire Discovery Institute to its ever-growing roster of partners for its drug discovery engine.

Okta Ventures contributed to a $60m round for device management platform developer Kandji while real estate data provider Cherre raised $50m from investors including Intel Capital.

The Medtronic and Johnson & Johnson-backed epilepsy treatment system provider floated at the top of its range and saw its shares rise 47% on their first day.

University of Auckland’s Rain Therapeutics has priced shares at $17 each to raise $125m in its initial public offering.

Chemicals company DSM and bank Rabo as limited partners in BVP Fund IV.